DaVita Expands Operations into Latin America
DaVita®, a division of DaVita HealthCare Partners (NYSE: DVA) and a leading provider of kidney care services, today announced it has taken majority ownership of Esensa S.A.S., the largest independent renal services provider in Colombia.
“This is a major milestone for DaVita,” said Dennis Kogod, chief operating officer of DaVita HealthCare Partners. “In the United States and nine other countries worldwide, we've focused on caring for our patients, our teammates and our communities. We're proud to now include Latin America in this record of excellence and bring Esensa S.A.S. into the DaVita Village.”
The new joint venture encompasses seven clinics treating nearly 1,500 patients in Bogota, Cali, Medellin and Barranquilla. Over the coming years, DaVita plans to expand services in these cities and in other cities of Colombia through this venture. The focus of the expansion will be on providing kidney disease patients the quality of care and service that has long been one of Esensa's distinctive characteristics.
“With such a strong emphasis on continuous improvement of our services, innovation and an unwavering focus on the people we serve, Esensa's values align wonderfully with DaVita's,” said Javier Uejbe, president of the Board of Directors of Esensa S.A.S. “It's a complementary partnership and together we can optimize results for our patients and for the Colombian health system.”
DaVita has achieved clinical outcomes that have improved year-over-year for more than a decade in the United States.
For more information on DaVita, please visit DaVita.com.
DaVita and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc. All other trademarks are the property of their respective owners.
DaVita is the dialysis division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of kidney care in the United States, DaVita delivers dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of March 31, 2013, DaVita operated or provided administrative services at 1,991 outpatient dialysis centers located in the United States serving approximately 156,000 patients. The company also operated 41 outpatient dialysis centers located in nine countries outside the United States. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company's leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit DaVita.com.
This release contains forward-looking statements within the meaning of the federal securities laws, including statements related to anticipated and prospective growth of certain of our international ventures and the clinical outcomes that they will deliver. Factors which could impact future results include the risks and uncertainties associated with expansion of our operations and services to markets outside the United States, governmental regulations, general economic and other market conditions, competition, and the risk factors set forth in our SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2012, and subsequent quarterly reports filed on Form 10-Q. The forward-looking statements should be considered in light of these risks and uncertainties. We base our forward-looking statements on information currently available to us at the time of this release, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of changes in underlying factors, new information, future events or otherwise.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.